These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 8860238

  • 1. Reserpine- and tetrabenazine-sensitive transport of (3)H-histamine by the neuronal isoform of the vesicular monoamine transporter.
    Erickson JD, Eiden LE, Schafer MK, Weihe E.
    J Mol Neurosci; 1995; 6(4):277-87. PubMed ID: 8860238
    [Abstract] [Full Text] [Related]

  • 2. Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter.
    Erickson JD, Schafer MK, Bonner TI, Eiden LE, Weihe E.
    Proc Natl Acad Sci U S A; 1996 May 14; 93(10):5166-71. PubMed ID: 8643547
    [Abstract] [Full Text] [Related]

  • 3. Localization of vesicular monoamine transporter isoforms (VMAT1 and VMAT2) to endocrine cells and neurons in rat.
    Weihe E, Schäfer MK, Erickson JD, Eiden LE.
    J Mol Neurosci; 1994 May 14; 5(3):149-64. PubMed ID: 7654518
    [Abstract] [Full Text] [Related]

  • 4. Vesicular amine transporter expression and isoform selection in developing brain, peripheral nervous system and gut.
    Schütz B, Schäfer MK, Eiden LE, Weihe E.
    Brain Res Dev Brain Res; 1998 Mar 12; 106(1-2):181-204. PubMed ID: 9555003
    [Abstract] [Full Text] [Related]

  • 5. Individual residues contribute to multiple differences in ligand recognition between vesicular monoamine transporters 1 and 2.
    Finn JP, Edwards RH.
    J Biol Chem; 1997 Jun 27; 272(26):16301-7. PubMed ID: 9195934
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Differential expression of two vesicular monoamine transporters.
    Peter D, Liu Y, Sternini C, de Giorgio R, Brecha N, Edwards RH.
    J Neurosci; 1995 Sep 27; 15(9):6179-88. PubMed ID: 7666200
    [Abstract] [Full Text] [Related]

  • 9. Expression of the two isoforms of the vesicular monoamine transporter (VMAT1 and VMAT2) in the endocrine pancreas and pancreatic endocrine tumors.
    Anlauf M, Eissele R, Schäfer MK, Eiden LE, Arnold R, Pauser U, Klöppel G, Weihe E.
    J Histochem Cytochem; 2003 Aug 27; 51(8):1027-40. PubMed ID: 12871984
    [Abstract] [Full Text] [Related]

  • 10. Biochemistry and molecular biology of the vesicular monoamine transporter from chromaffin granules.
    Henry JP, Botton D, Sagne C, Isambert MF, Desnos C, Blanchard V, Raisman-Vozari R, Krejci E, Massoulie J, Gasnier B.
    J Exp Biol; 1994 Nov 27; 196():251-62. PubMed ID: 7823026
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Multiple residues contribute independently to differences in ligand recognition between vesicular monoamine transporters 1 and 2.
    Finn JP, Edwards RH.
    J Biol Chem; 1998 Feb 13; 273(7):3943-7. PubMed ID: 9461580
    [Abstract] [Full Text] [Related]

  • 15. Vesicular monoamine transporters in the rat stomach.
    Hunyady B, Palkovits M, Mezey E.
    J Physiol Paris; 2000 Feb 13; 94(2):123-30. PubMed ID: 10791693
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Apparent opposite effects of tetrabenazine and reserpine on the toxic effects of 1-methyl-4-phenylpyridinium or 6-hydroxydopamine on nigro-striatal dopaminergic neurons.
    Cleren C, Naudin B, Costentin J.
    Brain Res; 2003 Nov 07; 989(2):187-95. PubMed ID: 14556940
    [Abstract] [Full Text] [Related]

  • 18. Characterization of high-affinity [3H]TBZOH binding to the human platelet vesicular monoamine transporter.
    Zucker M, Weizman A, Rehavi M.
    Life Sci; 2001 Sep 28; 69(19):2311-7. PubMed ID: 11669473
    [Abstract] [Full Text] [Related]

  • 19. Reserpine or chronic paroxetine treatments do not modify the vesicular monoamine transporter 2 expression in serotonin-containing regions of the rat brain.
    Vilpoux C, Leroux-Nicollet I, Naudon L, Raisman-Vozari R, Costentin J.
    Neuropharmacology; 2000 Apr 03; 39(6):1075-82. PubMed ID: 10727718
    [Abstract] [Full Text] [Related]

  • 20. Identification of a novel, inhibitory action of amiodarone on vesicular monoamine transport.
    Haikerwal D, Dart AM, Little PJ, Kaye DM.
    J Pharmacol Exp Ther; 1999 Feb 03; 288(2):834-7. PubMed ID: 9918596
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.